Literature DB >> 16770438

Cognitive-behavioral treatment for social phobia in Parkinson's disease: A single-case study.

Nina Heinrichs1, Emily C Hoffman, Stefan G Hofmann.   

Abstract

Individuals with Parkinson's disease often exhibit symptoms of social anxiety. However, they rarely meet criteria for social phobia due to the medical exclusion criteria of DSM-IV. The present study reports the case of a 60-year-old male with Parkinson's disease who also met criteria for social phobia. After receiving 12 weekly cognitive-behavioral group sessions for social phobia, clinician ratings and self-report measures at post-treatment and 6-month follow-up showed a significant short-term and long-term reduction of his social anxiety. These findings suggest that cognitive-behavior therapy may be an effective treatment for social anxiety, even if these symptoms are related to Parkinson's disease.

Entities:  

Year:  2001        PMID: 16770438      PMCID: PMC1476697          DOI: 10.1016/S1077-7229(01)80005-5

Source DB:  PubMed          Journal:  Cogn Behav Pract        ISSN: 1077-7229


  14 in total

1.  Treatment of Social Phobia: Potential Mediators and Moderators.

Authors:  Stefan G Hofmann
Journal:  Clin Psychol (New York)       Date:  2000-03

2.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

3.  Anxiety disorders in familial parkinsonism.

Authors:  E C Lauterbach; R C Duvoisin
Journal:  Am J Psychiatry       Date:  1991-02       Impact factor: 18.112

Review 4.  Neurobiological perspectives on social phobia: from affiliation to zoology.

Authors:  M B Stein
Journal:  Biol Psychiatry       Date:  1998-12-15       Impact factor: 13.382

5.  Self-focused attention before and after treatment of social phobia.

Authors:  S G Hofmann
Journal:  Behav Res Ther       Date:  2000-07

6.  Social phobia.

Authors:  M R Liebowitz
Journal:  Mod Probl Pharmacopsychiatry       Date:  1987

Review 7.  Anxiety and Parkinson's disease.

Authors:  I H Richard; R B Schiffer; R Kurlan
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1996       Impact factor: 2.198

8.  A composite measure to determine improvement following treatment for social phobia: the Index of Social Phobia Improvement.

Authors:  S M Turner; D C Beidel; P L Wolff
Journal:  Behav Res Ther       Date:  1994-05

9.  Anxiety disorders in patients with Parkinson's disease.

Authors:  M B Stein; I J Heuser; J L Juncos; T W Uhde
Journal:  Am J Psychiatry       Date:  1990-02       Impact factor: 18.112

View more
  6 in total

Review 1.  The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease.

Authors:  Gretchen O Reynolds; Michael W Otto; Terry D Ellis; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2015-12-30       Impact factor: 10.338

Review 2.  Systematic Review of the Clinical Application of Exposure Techniques to Community-Dwelling Older Adults with Anxiety.

Authors:  Nimali Jayasinghe; Lucy Finkelstein-Fox; Lili Sar-Graycar; Mary-Jane Ojie; Martha L Bruce; JoAnn Difede
Journal:  Clin Gerontol       Date:  2017-02-06       Impact factor: 2.619

3.  Drug Choices and Advancements for Managing Depression in Parkinson's Disease.

Authors:  Francesca Assogna; Clelia Pellicano; Cinzia Savini; Lucia Macchiusi; Gaia R Pellicano; Marika Alborghetti; Carlo Caltagirone; Gianfranco Spalletta; Francesco E Pontieri
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

4.  A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson's disease.

Authors:  Lakkhina Troeung; Sarah J Egan; Natalie Gasson
Journal:  BMC Psychiatry       Date:  2014-01-27       Impact factor: 3.630

5.  A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's disease.

Authors:  Lakkhina Troeung; Sarah J Egan; Natalie Gasson
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

6.  Evaluation of quality of life and psychological aspects of Parkinson's disease patients who participate in a support group.

Authors:  Nathalie Ribeiro Artigas; Vera Lúcia Widniczck Striebel; Arlete Hilbig; Carlos Roberto de Mello Rieder
Journal:  Dement Neuropsychol       Date:  2015 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.